EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays

Lara Goscé iD, Kasim Allel iD, Yohhei Hamada iD, Elena Surkova, Irina Kontsevaya, Ting Ting Wang, Wan-Hsin Liu iD, Alexander Matveev, Liliya Eugenevna Ziganshina iD, Alexei Korobitsyn, Nazir Ismail, Saima Bashir iD und 4 weitere

PLOS Global Public Health · 14.10.2024 · 4 (10) · e0003655

DOI: 10.1371/journal.pgph.0003655 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Global Public Health, online erschienen am 14.10.2024. Verfasst von Lara Goscé und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Health, University College London, London, United Kingdom. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, WHO Global TB Programme, Medical Research Council (MRC) Centre for Global Infectious Disease Analysis.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Purified Protein Derivative tuberculin skin tests (TST) and blood-based Mycobacterium tuberculosis (M . tb) specific interferon-gamma release assays (IGRA) are the currently used tests for identifying individuals with TB infection for preventive treatment. However, challenges around access and implementation have limited their use. Novel M . tb specific skin tests (TBST) such as Diaskintest, ESAT6-CFP10 (C-TST), C-Tb (also known as Cy-Tb), and DPPD may provide accurate and scalable options but evidence synthesis on their economic impact is lacking. We conducted two separate systematic reviews to compare the costs and cost-effectiveness of (1) the novel skin tests TBST (primary), and (2) TST and IGRA tests (secondary), to support WHO guideline development. We searched for articles presenting economic evaluations of the diagnostic tests using a health provider perspective and related to TB infection in humans. We considered papers written in English, Chinese or Russian. In the primary review, eight studies for novel TBST were found. One study in Brazil assessed cost-effectiveness of C-TST and Diaskintest and seven in Russia assessed the Diaskintest, while none evaluated C-Tb or DPPD. The review showed on average, Diaskintest kit costs (in 2021 USD) $1.60 (1.50 – 1.70), while full unit costs were estimated at $5.07. C-TST unit cost was $9.96. The second review found 32 articles on IGRA and/or the TST. These presented an average TST full unit cost of $37.88, and $87.81 for IGRA. Studies’ quality for TBST was limited while high-quality studies were found for TST and IGRA tests. In conclusion, there is limited evidence regarding the costs and cost-effectiveness of novel TBST. Conversely, there is substantial evidence for TST and IGRA tests, but most studies were performed in high-income and low-TB burden settings and their cost-effectiveness varied between and within risk groups without clear economic consensus.

Autor:innen und Institutionen

  • Institute for Global Health, University College London, London, United Kingdom.
  • Department of Infectious Disease Epidemiology, TB Modelling Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Royal Brompton Hospital, Part of Guy's and St Thomas' NHS Foundation Trust London, London, United Kingdom.
  • Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
  • German Center for Infection Research, Braunschweig, Germany.

ORCID-Profile: Lara Goscé, Kasim Allel, Yohhei Hamada, Wan-Hsin Liu, Liliya Eugenevna Ziganshina, Saima Bashir

Förderung

  • World Health Organization
  • WHO Global TB Programme
  • Medical Research Council (MRC) Centre for Global Infectious Disease Analysis
  • National Institute for Health Research

Zitieren

APA

Goscé, L., Allel, K., Hamada, Y., Surkova, E., Kontsevaya, I., Wang, T. T., Liu, W. H., Matveev, A., Ziganshina, L. E., Korobitsyn, A., Ismail, N., Bashir, S., Denkinger, C. M., Abubakar, I., White, P. J., & Rangaka, M. X. (2024). Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays. PLOS Global Public Health, 4(10), e0003655. https://doi.org/10.1371/journal.pgph.0003655

Vancouver

Goscé L, Allel K, Hamada Y, Surkova E, Kontsevaya I, Wang TT, et al. Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays. PLOS Global Public Health. 2024;4(10):e0003655. doi:10.1371/journal.pgph.0003655

BibTeX
@article{Gosc2024,
  author = {Goscé, Lara and Allel, Kasim and Hamada, Yohhei and Surkova, Elena and Kontsevaya, Irina and Wang, Ting Ting and Liu, Wan-Hsin and Matveev, Alexander and Ziganshina, Liliya Eugenevna and Korobitsyn, Alexei and Ismail, Nazir and Bashir, Saima and Denkinger, Claudia M and Abubakar, Ibrahim and White, Peter J and Rangaka, Molebogeng X},
  title = {Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays},
  journal = {PLOS Global Public Health},
  year = {2024},
  volume = {4},
  number = {10},
  pages = {e0003655},
  doi = {10.1371/journal.pgph.0003655}
}
Kostenlos starten →